The present invention relates to prostate cancer (PCa). More specifically, the invention provides a MST1 phospho-threonine (pMST1-T120) antibody that can be used in various assays to study correlations between Mst1 function and T120 site phosphorylation. The present invention can also be used to determine disease development and/or progression of prostate cancer in a subject using the antibodies disclosed herein.
申请公布号
WO2012024643(A3)
申请公布日期
2012.05.03
申请号
WO2011US48508
申请日期
2011.08.19
申请人
CEDARS-SINAI MEDICAL CENTER;CINAR, BEKIR;COLLAK, FILIZ KISAAYAK